A kind of wound healing paste for promoting tissue regeneration and pain relieving and preparation method thereof

By using the combination of Chinese medicinal materials such as elephant skin and blood dysfunction and sesame oil beeswax, the preparation process of the muscle-generating pain relief cream is simplified, the problems of complex preparation and poor efficacy in the existing technology are solved, and rapid and effective wound healing is achieved and pain relief.

CN118787702BActive Publication Date: 2024-11-22TRADITIONAL CHINESE MEDICINE HOSPITAL OF INNER MONGOLIA AUTONOMOUS REGION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411278747.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-11-22
Estimated Expiration
2044-09-12

AI Technical Summary

Technical Problem

The existing preparation methods for muscle-generating and pain relief creams are complex, which affect the efficacy of the effective ingredients. The pain relief and muscle rejuvenation strength is weak, the healing cycle is long, and there is a risk of slow healing or non-healing.

Method used

Using elephant skin, blood dysfunction, yamus, angelica, angelica, cypress, cypress, elm, syrup and seaweed as raw materials, combined with sesame oil and beeswax as substrates, the muscle-generating pain relief cream was prepared by soaking, decocting and stirring, which simplified the The preparation process improves the dissolution and bioavailability of the active pharmaceutical ingredients.

Benefits of technology

It significantly improves the bioavailability of the active ingredients of the drug, promotes wound healing, reduces healing cycles, enhances pain-relieving and anti-inflammatory effects, improves local blood circulation, and promotes tissue repair.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118787702B_ABST
    Figure CN118787702B_ABST
Patent Text Reader

Abstract

The present application relates to the technical field of traditional Chinese medicine ointments, and specifically discloses a wound healing myogenic analgesic ointment and a preparation method thereof. The wound healing myogenic analgesic ointment comprises raw materials of elephant skin, dragon's blood, corydalis, sanguisorba officinalis, lithospermum officinale, angelica dahurica, rubescens herb, seaweed, sesame oil and beeswax; the preparation method thereof comprises: corydalis, sanguisorba officinalis, lithospermum officinale, angelica dahurica, rubescens herb and seaweed are powdered together and then extracted to obtain a mixed extract; sesame oil is decocted over a slow fire until the oil boils, beeswax is added to melt, and then the fire is turned off, elephant skin powder and the remaining mixed powder are added while stirring, and after the system temperature is lower than 40°C, blood scorpion powder and the mixed extract are added and blended evenly, cooled to a paste, and allowed to stand at room temperature to obtain the ointment; the present application has simple ingredients, a clear mechanism of action, and a simple preparation method, can significantly improve the solubility of active drug ingredients, and improve the bioavailability of active drug ingredients, and does not need to be combined with other treatment methods, and has a significant effect on wound healing after perianal abscess surgery.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of traditional Chinese medicine ointments, and more specifically, to a tissue-generating and analgesic ointment for wound healing and a preparation method thereof. Background Art

[0002] Perianal abscess is an emergency in the anorectal department, with an incidence rate of about 25% of anorectal diseases, and it is more common in men. Traditional Chinese medicine believes that it is mostly caused by dampness, heat and other evil qi, which cause poor qi movement, blocked meridians, unclear clear and turbid qi, stagnation and toxicity, and damage to the soul gate. Although the visible evil toxins on the wound surface after surgery have been removed, the invisible depression toxins still exist, which stagnate the soul gate, and pain will occur if it is not smooth; in addition, the tendons and veins on the wound surface are damaged, and the qi and blood are not nourished, which will cause pain, easily forming qi stagnation and blood stasis, and the remaining toxins are not completely cleared. Western medicine believes that this disease is mainly caused by infection of the anal crypts, and the pathogens extend to the anal glands along the anal gland ducts and spread to the anorectal area. The postoperative period is equivalent to the ulceration period of "anal carbuncle", "visceral toxin" and "fecal carbuncle" in traditional Chinese medicine. The wound repair belongs to the secondary healing. The wound healing has the following characteristics: ① Degeneration and necrosis of infected tissue and severe inflammatory response. Regeneration can only occur after the infection is controlled and the necrotic tissue is cleared, and the epidermal regeneration time is delayed; ② The infection can stimulate the wound to secrete a variety of inflammatory mediators (cytokines, lipid metabolites, etc.), causing tissue damage and forming infection complications; ③ Bacterial toxins after infection cause tissue necrosis and suppuration, leading to delayed healing; ④ Bacterial toxins cause thrombosis, affecting tissue blood supply.

[0003] The wound surface of perianal abscess after surgery is large and the pain is severe. The wound surface is affected by infection, mechanical stimulation, microecology and other factors, and there is a risk of slow healing or even non-healing. In addition to internal treatment, there are many reports on external treatment methods of traditional Chinese medicine such as Shengji Yuhong ointment and Huanglian ointment in clinical practice. The applicant's previously published document "The Effect of Shengji Pain-relieving Ointment on Wound Healing and Related Growth Factor Expression after Perianal Abscess Surgery, Zhao Xiaole et al., May 2023" discloses the preparation of Shengji Pain-relieving Ointment Gauze, using Panax notoginseng, Angelica sinensis, Lithospermum officinale, Licorice, Angelica dahurica, Sanguisorba officinalis, Borneol, Vinegar Corydalis, Sanguisorba officinalis, Sesame oil, white vaseline, etc. as raw materials, and the Shengji Pain-relieving Ointment Gauze is prepared by soaking, decoction, concentration, cream collection, and ointment yarn making. The Shengji Pain-relieving Ointment has obvious effects of removing blood stasis and relieving pain, clearing away heat and detoxification, nourishing blood and promoting muscle regeneration, but the preparation method is complicated, which not only increases the operation time, but also affects the efficacy of the effective ingredients. There are defects such as weak analgesic and muscle regeneration and long healing period. Based on the above statements, the present application provides a tissue-generating and analgesic ointment for wound healing and a preparation method thereof. Summary of the invention

[0004] In order to solve the problems that the existing preparation method of tissue regeneration and analgesic ointment is complicated, which not only increases the operation time, but also affects the efficacy of the effective ingredients, and has defects such as weak analgesic and tissue regeneration effect and a long healing period, the present application provides a tissue regeneration and analgesic ointment for wound healing and a preparation method thereof.

[0005] In the first aspect, the present application provides a wound healing myogenic analgesic ointment, which adopts the following technical solution:

[0006] A tissue-generating and analgesic ointment for wound healing comprises a raw material medicine and a matrix. The raw material medicine is composed of the following raw materials in parts by mass: 30-50 parts of elephant skin, 24-28 parts of dragon's blood, 30-50 parts of corydalis, 15-25 parts of angelica dahurica, 28-40 parts of lithospermum officinale, 12-18 parts of sanguisorba officinalis, 10-15 parts of rubescens and 10-15 parts of seaweed.

[0007] Preferably, the raw material medicine is composed of the following raw materials in parts by mass: 40 parts of elephant bark, 25 parts of dragon's blood, 40 parts of Corydalis yanhusuo, 20 parts of angelica dahurica, 30 parts of lithospermum officinale, 15 parts of sanguisorba officinalis, 12 parts of rubescens, and 12 parts of seaweed.

[0008] Preferably, the matrix comprises 700-900 parts of sesame oil and 180-250 parts of beeswax.

[0009] Preferably, the matrix includes 800 parts of sesame oil and 200 parts of beeswax.

[0010] In the second aspect, the present application provides a method for preparing a wound healing myogenic analgesic ointment, using the following technical solution:

[0011] A method for preparing a wound healing ointment comprising the following steps:

[0012] S1, respectively grinding elephant skin and dragon's blood to obtain elephant skin powder and dragon's blood powder, and grinding Corydalis yanhusuo, angelica dahurica, lithospermum officinale, sanguisorba officinalis, rubescens herb and seaweed to obtain mixed powder;

[0013] S2, taking 50-80% of the weight of the mixed powder, extracting it with anhydrous ethanol and deionized water in turn, concentrating, drying and pulverizing it to obtain a mixed extract;

[0014] S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add elephant skin powder and the remaining mixed powder while stirring, continue stirring until the system temperature is below 40°C, then add dragon's blood powder and the mixed extract to mix evenly, cool to a paste, and let stand at room temperature to obtain the desired tissue-growing and analgesic ointment.

[0015] Preferably, the elephant skin powder in step S1 is prepared by the following method: talcum powder is heated to 100-120° C. at a mass ratio of 1-2:1, and then poured into elephant skin cut into thin strips. When the elephant skin is scalded to bulge and turn brown, the talcum powder is sieved out, and the treated elephant skin is cooled and then ground into 100-150 mesh to obtain elephant skin powder.

[0016] Preferably, the dragon's blood powder in step S1 is prepared by the following method: soaking the dragon's blood in deionized water for 1-2 hours until softened, blanching it in boiling water for 3-7 minutes for sterilization, drying it, and grinding it into 100-150 meshes to obtain the dragon's blood powder.

[0017] Preferably, the mixed drug powder in step S1 is sieved through a 100-150 mesh sieve.

[0018] Preferably, the specific operation steps of step S2 are as follows:

[0019] Take 50-80% of the weight of the mixed powder and add anhydrous ethanol to reflux extract 1-3 times, combine the ethanol extract, add deionized water to the extracted drug residue and reflux extract 1-3 times, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30-1.36 at 80°C, dry at 60-80°C, and then grind into 100-150 mesh to obtain a mixed extract.

[0020] In a third aspect, the present application provides an application of a wound healing ointment for promoting tissue regeneration and relieving pain, using the following technical solution:

[0021] Application of a tissue-generating and analgesic ointment for wound healing in the preparation of a drug for promoting postoperative wound healing of perianal abscesses.

[0022] In summary, this application has the following beneficial effects:

[0023] The tissue regeneration and analgesic ointment proposed in the present application uses elephant skin, dragon's blood, Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis, Rubescens rubescens and seaweed as raw materials, and sesame oil and beeswax as matrix, with simple formula ingredients and clear mechanism of action; the ointment is prepared by decocting sesame oil over low heat until the oil boils, then adding beeswax, turning off the heat after the beeswax melts, adding elephant skin powder and the remaining mixed powder while stirring, continuing to stir until the system temperature is lower than 40°C, then adding dragon's blood powder and the mixed extract to mix evenly, cooling to a paste, and standing at room temperature to obtain the desired tissue regeneration and analgesic ointment, the preparation method is simple, can significantly improve the solubility of the active ingredients of the drug, improve the bioavailability of the active ingredients of the drug, does not need to be combined with other treatment methods, and has a significant effect on the healing of postoperative wounds of perianal abscesses.

[0024] The tissue-promoting and pain-relieving ointment proposed in the present application uses elephant peel and Sanguisorba officinalis as the main medicine. The elephant peel has the effects of hemostasis and convergence, can effectively control wound exudation, and provide a healing environment; and Sanguisorba officinalis has the effect of strong hemostasis and promotion of tissue regeneration, which can directly promote the healing of wounds. Using Corydalis yanhusuo and Angelica dahurica as the ministerial medicine, the blood circulation and stasis-removing and swelling-removing and pain-relieving effects of Corydalis yanhusuo and Angelica dahurica can enhance the effect of the main medicine, improve local blood circulation, and promote healing. Using Lithospermum officinale as the adjuvant, Lithospermum officinale has the effects of clearing away heat and detoxicating, and swelling-removing, can help control inflammation, resist infection, and support the effect of the main medicine. Using Sanguisorba officinalis, Rubescens herb and Seaweed as adjuvant drugs, Sanguisorba officinalis has the effects of clearing away heat and detoxifying, stopping bleeding and astringing, can effectively control wound exudation and promote tissue repair; Rubescens herb has the effects of clearing away heat and detoxifying, antibacterial and anti-inflammatory, can inhibit the growth of pathogenic microorganisms, reduce inflammatory response, and help reduce exudate; Seaweed has the effects of softening and relieving swelling, and clearing away heat, can improve blood circulation, help discharge pus accumulated in the body, and promote wound healing; Using Sanguisorba officinalis, Rubescens herb and Seaweed as adjuvant drugs together, the three complement each other in terms of action mechanism. Sanguisorba officinalis and Rubescens herb can jointly inhibit bacterial growth and reduce inflammation, while Seaweed can help improve local blood circulation, promote pus discharge and tissue repair, and the multiple effects can guide and enhance the overall efficacy, make the formula components synergistic, ensure the pertinence and effectiveness of the drug, and accelerate the healing process.

[0025] The muscle-generating analgesic cream proposed in this application uses sesame oil and beeswax as the matrix. Sesame oil is rich in a variety of unsaturated fatty acids and vitamins (such as vitamin E), which has a nutritional effect on the skin and helps to accelerate healing and repair. Its good permeability and moisturizing properties can help the active ingredients of the drug penetrate into the skin and help maintain a moist environment for the wound; beeswax has natural antibacterial properties, which can protect the wound and prevent wound infection; the two together serve as a matrix with moderate viscosity, making the paste easy to apply and absorb, and can form a protective film on the skin surface, while providing a good release environment for the drug, it can prevent external stimulation and water loss, and protect the wound from pollution. Compared with the combination of sesame oil and white vaseline, the matrix combination in this application is more natural in composition, and the natural ingredients in sesame oil and the antioxidant properties of beeswax help to improve the stability and use effect of the product, while white vaseline is mainly used as a sealant. Although it can moisturize, it lacks nutrients and auxiliary healing functions. The muscle-generating analgesic cream of this application is more easily absorbed by the skin, will not clog the pores, and can provide patients with a better experience and effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 This is a comparison chart of wound healing rates among group 1 of Example 1, the model control group, and the positive control group of the present application;

[0027] Figure 2 This is a scoring chart of wound secretions of rats in Example 1, model control group, and positive control group of the present application;

[0028] Figure 3 This is a diagram showing pathological changes in wound tissues of rats in the blank control group, model control group, Example 1 group, and positive control group of this application;

[0029] Figure 4 This is a graph showing the percentage of collagen area in the blank control group, Example 1 group, model control group, and positive control group of the present application;

[0030] Figure 5 This is a diagram showing pathological changes in wound tissues of rats in the blank control group, model control group, Example 1 group, and positive control group of this application;

[0031] Figure 6 This is a comparison chart of the positive rates of PCNA protein expression in rats in group 1 of Example 1 of the present application, the positive control group, the blank control group, and the model control group;

[0032] Figure 7 This is a graph showing the PCNA expression in the wound tissue of rats in the blank control group, model control group, Example 1 group, and positive control group of this application;

[0033] Figure 8 This is a comparison chart of VEGF concentration values ​​in the rat serum of the blank control group, Example 1 group, positive control group, and model control group of this application;

[0034] Fig. 9 This is a comparison chart of the bFGF concentration values ​​in the peripheral blood of rats in Example 1, the blank control group, the model control group, and the positive control group of the present application;

[0035] Fig.10 This is a comparison chart of Ang-1 concentration values ​​in peripheral blood of rats in the blank control group, Example 1 group, model control group, and positive control group of this application;

[0036] Fig.11 This is a diagram showing the wound healing status of rats in the model control group, positive control group, and Example 1 group at different time points in this application. DETAILED DESCRIPTION

[0037] The present application is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the scope of the present invention.

[0038] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.

[0039] The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples are commercially available products unless otherwise specified.

[0040] Embodiment 1-3 provides a wound healing tissue regeneration and pain relieving ointment and a preparation method thereof.

[0041] Example 1

[0042] A tissue-generating and analgesic ointment for wound healing is composed of the following raw materials: 30g of elephant skin, 24g of dragon's blood, 30g of corydalis, 15g of angelica dahurica, 28g of lithospermum officinale, 12g of sanguisorba officinalis, 10g of rubescens, 10g of seaweed, 700g of sesame oil and 180g of beeswax.

[0043] A method for preparing a wound healing ointment comprising the following steps:

[0044] S1, according to the mass ratio of 1:1, talcum powder is heated to 100 ° C and poured into the elephant skin cut into thin strips, until the elephant skin is scalded to bulge and turn brown, talcum powder is sieved out, and the elephant skin to be treated is cooled and ground into 100 mesh to obtain elephant skin powder;

[0045] Soak the dragon's blood in deionized water for 1 hour until softened, blanch it in boiling water for 7 minutes to sterilize it, dry it at 60°C, and grind it into 100 meshes to obtain dragon's blood powder;

[0046] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis, Rubescens rubescens and seaweed at 60°C, and grinding into 100 meshes to obtain mixed powder;

[0047] S2, take 50% of the weight of the mixed powder and add anhydrous ethanol to extract it once, combine the ethanol extract, add deionized water to the extracted drug residue and extract it once, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30 at 80°C, dry at 60°C and grind into 100 mesh to obtain a mixed extract;

[0048] S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add elephant skin powder and the remaining mixed powder at a speed of 80 rpm while stirring, continue stirring until the system temperature reaches 35°C, add dragon's blood powder and the mixed extract, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0049] Example 2

[0050] A tissue-generating and analgesic ointment for wound healing is composed of the following raw materials: 40g of elephant skin, 25g of dragon's blood, 40g of corydalis, 20g of angelica dahurica, 30g of lithospermum officinale, 15g of sanguisorba officinalis, 12g of rubescens, 12g of seaweed, 800g of sesame oil and 200g of beeswax.

[0051] A method for preparing a wound healing ointment comprising the following steps:

[0052] S1, according to the mass ratio of 1.5:1, talcum powder is heated to 110 ℃ and poured into the elephant skin cut into thin strips, until the elephant skin is scalded to bulge and is brown, talcum powder is sieved out, and the elephant skin to be treated is cooled and ground into 120 mesh to obtain elephant skin powder;

[0053] Soak the dragon's blood in deionized water for 1.5 hours until softened, blanch it in boiling water for 5 minutes to sterilize it, dry it at 60°C, and grind it into 120 mesh to obtain dragon's blood powder;

[0054] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis, Rubescens rubescens and seaweed at 60°C, and grinding into 120 meshes to obtain mixed powder;

[0055] S2, take 65% of the weight of the mixed powder and add anhydrous ethanol to reflux extract twice, combine the ethanol extract, add deionized water to the extracted drug residue and reflux extract twice, combine the water extract, and concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, and then concentrate to a thick paste with a relative density of 1.33 at 80°C, dry at 70°C, and grind into 120 mesh to obtain a mixed extract;

[0056] S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add elephant skin powder and the remaining mixed powder at a speed of 80 rpm while stirring, continue stirring until the system temperature reaches 35°C, add dragon's blood powder and the mixed extract, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0057] Example 3

[0058] A tissue-generating and analgesic ointment for wound healing is composed of the following raw materials: 50g of elephant skin, 28g of dragon's blood, 50g of corydalis, 25g of angelica dahurica, 40g of lithospermum officinale, 18g of sanguisorba officinalis, 15g of rubescens, 15g of seaweed, 900g of sesame oil and 250g of beeswax.

[0059] A method for preparing a wound healing ointment comprising the following steps:

[0060] S1, according to the mass ratio of 2: 1, talcum powder is heated to 120 ℃ and poured into the elephant skin cut into thin strips, until the elephant skin is scalded to bulge and turn brown, talcum powder is sieved out, and the elephant skin to be treated is cooled and ground into 150 mesh to obtain elephant skin powder;

[0061] Soak the dragon's blood in deionized water for 2 hours until softened, blanch it in boiling water for 3 minutes to sterilize it, dry it at 60°C, and grind it into 150 meshes to obtain dragon's blood powder;

[0062] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis, Rubescens rubescens and seaweed at 60°C, and grinding into 150 meshes to obtain mixed powder;

[0063] S2, take 80% of the weight of the mixed powder and add anhydrous ethanol to reflux and extract 3 times, combine the ethanol extract, add deionized water to the extracted drug residue and reflux and extract 3 times, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.36 at 80°C, dry at 80°C and crush into 150 mesh to obtain a mixed extract;

[0064] S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add elephant skin powder and the remaining mixed powder at a speed of 80 rpm while stirring, continue stirring until the system temperature reaches 35°C, add dragon's blood powder and the mixed extract, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0065] In order to verify the therapeutic effect of the wound healing myogenic analgesic ointment prepared in Examples 1-3 of the present application, the applicant set up comparative examples 1-6, which are as follows:

[0066] Comparative Example 1

[0067] A tissue-generating and analgesic ointment for wound healing is composed of the following raw materials: 24g of Sanguisorba officinalis, 30g of Corydalis yanhusuo, 15g of Angelica dahurica, 28g of Lithospermum officinale, 12g of Sanguisorba officinalis, 10g of Rabdosia rubescens, 10g of seaweed, 700g of sesame oil and 180g of beeswax.

[0068] A method for preparing a wound healing ointment comprising the following steps:

[0069] S1. Soak the dragon's blood in deionized water for 1 hour until softened, blanch it in boiling water for 7 minutes for sterilization, dry it at 60°C, and grind it into 100 meshes to obtain dragon's blood powder;

[0070] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis, Rubescens rubescens and seaweed at 60°C, and grinding into 100 meshes to obtain mixed powder;

[0071] S2, take 50% of the weight of the mixed powder and add anhydrous ethanol to extract it once, combine the ethanol extract, add deionized water to the extracted drug residue and extract it once, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30 at 80°C, dry at 60°C and grind into 100 mesh to obtain a mixed extract;

[0072] S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add the remaining mixed powder at a speed of 80 rpm while stirring, continue stirring until the system temperature reaches 35°C, add Dragon's Blood Powder and the mixed extract, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0073] Comparative Example 2

[0074] A tissue-generating and analgesic ointment for wound healing is composed of the following raw materials: 54g of Sanguisorba officinalis, 30g of Corydalis yanhusuo, 15g of Angelica dahurica, 28g of Lithospermum officinale, 12g of Sanguisorba officinalis, 10g of Rabdosia rubescens, 10g of seaweed, 700g of sesame oil and 180g of beeswax.

[0075] A method for preparing a wound healing ointment comprising the following steps:

[0076] S1. Soak the dragon's blood in deionized water for 1 hour until softened, blanch it in boiling water for 7 minutes for sterilization, dry it at 60°C, and grind it into 100 meshes to obtain dragon's blood powder;

[0077] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis, Rubescens rubescens and seaweed at 60°C, and grinding into 100 meshes to obtain mixed powder;

[0078] S2, take 50% of the weight of the mixed powder and add anhydrous ethanol to extract it once, combine the ethanol extract, add deionized water to the extracted drug residue and extract it once, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30 at 80°C, dry at 60°C and grind into 100 mesh to obtain a mixed extract;

[0079] S3. Boil sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add the remaining mixed powder at a speed of 80 rpm while stirring, continue stirring until the system temperature reaches 35°C, add Dragon's Blood Powder and the mixed extract, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0080] Comparative Example 3

[0081] The invention discloses a tissue-generating and pain-relieving ointment for wound healing, which is composed of the following raw materials: 30g of elephant skin, 24g of dragon's blood, 30g of corydalis, 15g of angelica dahurica, 28g of lithospermum officinale, 12g of sanguisorba officinalis, 20g of seaweed, 700g of sesame oil and 180g of beeswax.

[0082] A method for preparing a wound healing ointment comprising the following steps:

[0083] S1, according to the mass ratio of 1:1, talcum powder is heated to 100 ° C and poured into the elephant skin cut into thin strips, until the elephant skin is scalded to bulge and turn brown, talcum powder is sieved out, and the elephant skin to be treated is cooled and ground into 100 mesh to obtain elephant skin powder;

[0084] Soak the dragon's blood in deionized water for 1 hour until softened, blanch it in boiling water for 7 minutes to sterilize it, dry it at 60°C, and grind it into 100 meshes to obtain dragon's blood powder;

[0085] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis and seaweed at 60°C, and grinding into 100 meshes to obtain mixed powder;

[0086] S2, take 50% of the weight of the mixed powder and add anhydrous ethanol to extract it once, combine the ethanol extract, add deionized water to the extracted drug residue and extract it once, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30 at 80°C, dry at 60°C and grind into 100 mesh to obtain a mixed extract;

[0087] S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add elephant skin powder and the remaining mixed powder at a speed of 80 rpm while stirring, continue stirring until the system temperature reaches 35°C, add dragon's blood powder and the mixed extract, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0088] Comparative Example 4

[0089] A tissue-generating and analgesic ointment for wound healing is composed of the following raw materials: 30g of elephant skin, 24g of dragon's blood, 30g of corydalis, 15g of angelica dahurica, 28g of lithospermum officinale, 12g of sanguisorba officinalis, 20g of rubescens, 700g of sesame oil and 180g of beeswax.

[0090] A method for preparing a wound healing ointment comprising the following steps:

[0091] S1, according to the mass ratio of 1:1, talcum powder is heated to 100 ° C and poured into the elephant skin cut into thin strips, until the elephant skin is scalded to bulge and turn brown, talcum powder is sieved out, and the elephant skin to be treated is cooled and ground into 100 mesh to obtain elephant skin powder;

[0092] Soak the dragon's blood in deionized water for 1 hour until softened, blanch it in boiling water for 7 minutes to sterilize it, dry it at 60°C, and grind it into 100 meshes to obtain dragon's blood powder;

[0093] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis and Rubescens rubescens at 60°C, and grinding into 100 meshes to obtain mixed powder;

[0094] S2, take 50% of the weight of the mixed powder and add anhydrous ethanol to extract it once, combine the ethanol extract, add deionized water to the extracted drug residue and extract it once, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30 at 80°C, dry at 60°C and grind into 100 mesh to obtain a mixed extract;

[0095] S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add elephant skin powder and the remaining mixed powder at a speed of 80 rpm while stirring, continue stirring until the system temperature reaches 35°C, add dragon's blood powder and the mixed extract, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0096] Comparative Example 5

[0097] A tissue-generating and analgesic ointment for wound healing is composed of the following raw materials: 30g of elephant skin, 24g of dragon's blood, 30g of corydalis, 15g of angelica dahurica, 28g of lithospermum officinale, 12g of sanguisorba officinalis, 10g of rubescens, 10g of seaweed, 700g of sesame oil and 180g of beeswax.

[0098] A method for preparing a wound healing ointment comprising the following steps:

[0099] S1, according to the mass ratio of 1:1, talcum powder is heated to 100 ° C and poured into the elephant skin cut into thin strips, until the elephant skin is scalded to bulge and turn brown, talcum powder is sieved out, and the elephant skin to be treated is cooled and ground into 100 mesh to obtain elephant skin powder;

[0100] Soak the dragon's blood in deionized water for 1 hour until softened, blanch it in boiling water for 7 minutes to sterilize it, dry it at 60°C, and grind it into 100 meshes to obtain dragon's blood powder;

[0101] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis, Rubescens rubescens and seaweed at 60°C, and grinding into 100 meshes to obtain mixed powder;

[0102] S2, take the mixed powder and add anhydrous ethanol to reflux and extract once, combine the ethanol extract, add deionized water to the extracted drug residue and reflux and extract once, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30 at 80°C, dry at 60°C, and then grind into 100 mesh to obtain a mixed extract;

[0103] S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add elephant skin powder while stirring at a speed of 80 rpm, continue stirring until the system temperature reaches 35°C, add dragon's blood powder and mixed extracts, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0104] Comparative Example 6

[0105] A tissue-generating and analgesic ointment for wound healing is composed of the following raw materials: 30g of elephant peel, 24g of dragon's blood, 30g of corydalis, 15g of angelica dahurica, 28g of lithospermum officinale, 12g of sanguisorba officinalis, 10g of rubescens, 10g of seaweed, 700g of sesame oil and 180g of white vaseline.

[0106] A method for preparing a wound healing ointment comprising the following steps:

[0107] S1, according to the mass ratio of 1:1, talcum powder is heated to 100 ° C and poured into the elephant skin cut into thin strips, until the elephant skin is scalded to bulge and turn brown, talcum powder is sieved out, and the elephant skin to be treated is cooled and ground into 100 mesh to obtain elephant skin powder;

[0108] Soak the dragon's blood in deionized water for 1 hour until softened, blanch it in boiling water for 7 minutes to sterilize it, dry it at 60°C, and grind it into 100 meshes to obtain dragon's blood powder;

[0109] Drying Corydalis yanhusuo, Angelica dahurica, Lithospermum officinale, Sanguisorba officinalis, Rubescens rubescens and seaweed at 60°C, and grinding into 100 meshes to obtain mixed powder;

[0110] S2, take 50% of the weight of the mixed powder and add anhydrous ethanol to extract it once, combine the ethanol extract, add deionized water to the extracted drug residue and extract it once, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30 at 80°C, dry at 60°C and grind into 100 mesh to obtain a mixed extract;

[0111] S3. Simmer sesame oil over low heat until the oil boils, then add white vaseline. Turn off the heat after the white vaseline melts, add elephant skin powder and the remaining mixed powder at a speed of 80 rpm while stirring, continue stirring until the system temperature reaches 35°C, add dragon's blood powder and the mixed extract, mix evenly, cool to a paste, and let stand at room temperature for 72 hours to obtain the desired tissue-growing and analgesic ointment.

[0112] Wound healing effect test

[0113] The therapeutic effect tests were performed on the drug components prepared in Examples 1-3 of the present application and Comparative Examples 1-6, respectively.

[0114] Experimental animals

[0115] 120 specific pathogen-free SD rats, weighing (200±20.0) g, all male, were housed in single cages, illuminated with light, with room temperature controlled at 23°C, relative humidity 50%, and well-ventilated. During the experiment, the animals had free access to water and food, and were fed with normal feed.

[0116] Model preparation

[0117] All rats were fed adaptively for 3 days, with normal food and water intake, and the animal room environment was kept suitable and stable. If there were abnormal phenomena such as decreased appetite, diarrhea, mental depression, hair loss, etc., they were immediately eliminated. On the fourth day, the rats were randomly divided into 12 groups, with 10 rats in each group. Except for the blank control group, the remaining rats were prepared with abscess models.

[0118] Preparation of rat abscess model: Referring to the modeling method of Jiang Wei et al., the SD rats were weighed and recorded before the experiment, and anesthetized using a small animal gas anesthesia machine. After anesthesia, use a small animal razor to shave as much hair on the back of the rat as possible (because the perianal area of ​​the rat is small, the skin on the back of the rat simulates the perianal tissue), and then use a depilatory cream to completely remove the hair. After 2 minutes, rinse with saline and dry. After the depilatory treatment is completed, fix the back of the rat on the small animal test bench, disinfect the back with iodine twice, and inject 1.5 ml of Staphylococcus aureus (3×10 10 CFU / ml). Injection method: lift the middle skin of the rat's back, insert the needle tip slightly obliquely downward, inject all the bacterial solution to form a skin mound, and slowly rotate and withdraw the needle. On the third day, redness, swelling and induration appeared on the rat's back, with obvious tenderness and skin temperature of 33-39°C, indicating that the model was successful. Unqualified models were eliminated, and rats with excess numbers were randomly excluded. Referring to the modeling method of skin excision injury model by Fu Xiaobing et al., the diameter of the skin punch was adjusted to 2cm, and the punch and skin contact head were disinfected. A circular incision was made on the back of the rat with a successful abscess model, deep to the fascia, to simulate surgical debridement. Wipe the wound with sterile gauze or cotton swabs, and perform preliminary hemostasis on the wound.

[0119] Experimental groups and wound treatment

[0120] The 110 rats with successful modeling except the blank group were divided into Example 1-3 groups, Comparative Example 1-6 groups, Model control group, and Positive control group by random number method, with an average of 10 rats in each group.

[0121] Rats in Example 1-3 group and Comparative Example 1-6 group were treated with the muscle-generating and analgesic ointment prepared in Example 1-3 and Comparative Example 1-6, respectively. 1 ml of fecal supernatant was added 30 minutes before changing the dressing to simulate the fecal contamination of patients with perianal abscesses. Then they were rinsed with physiological saline, disinfected with iodine tincture, and finally coated with the muscle-generating and analgesic ointment with a thickness of about 1 mm.

[0122] The rats in the model control group were dripped with 1 ml of fecal supernatant 30 minutes before dressing change to simulate the fecal contamination of patients with perianal abscesses. The rats were then rinsed with normal saline and disinfected with iodine tincture, but no drug treatment was given.

[0123] 30 minutes before changing the dressing, 1 ml of fecal supernatant was dripped into the rats in the positive control group to simulate the fecal contamination of patients with perianal abscess. The rats were then rinsed with normal saline, disinfected with iodine tincture, and finally coated with the first-generation product Shengji Pain Relief Cream mentioned in the background technology with a thickness of about 1 mm.

[0124] The blank control group did not receive any treatment.

[0125] Observation indicators and detection methods

[0126] Wound healing rate

[0127] On the 3rd, 7th, and 14th days after medication, the wound area of ​​each group of rats was calculated using Image J software (the wound was considered healed when it was completely covered by epithelium). ±s indicates that the mean wound healing rate of each group at the same time point after injury was subjected to F test, and the means of the groups with P < 0.05 were further compared.

[0128] Calculation formula: healing rate = (initial area - unhealed area) / initial area × 100%;

[0129] The postoperative wound healing rates of rats in each group are shown in Table 1.

[0130] Table 1 Comparison of wound healing rates of rats in each group at different time points ( ±s,%)

[0131]

[0132] Note: In Table 1, a was compared with the model control group, P<0.05; b was compared with the comparative groups 1-6 and the positive control group, P<0.05.

[0133] From the results shown in Table 1 above, it can be seen that: 3 days after medication, the wound healing rate of rats in each group was low, and the difference was not statistically significant (P>0.05). As the medication time prolonged, the wound healing rate of rats in each group increased significantly. On the 7th and 14th days after medication, compared with the model control group, the wound healing rates of Example 1-3 groups, Comparative Example 1-6 groups, and the positive control group were higher, and the difference was statistically significant (P<0.05). Compared with the Comparative Example 1-6 groups and the positive control group, the wound healing rate of Example 1-3 groups was higher, and the differences were statistically significant (P<0.05). The above results show that the muscle-generating and analgesic ointment prepared in the present application and the first-generation product muscle-generating and analgesic ointment mentioned in the background technology can both promote wound healing, but the muscle-generating and analgesic ointment prepared in the present application has more significant therapeutic effects. Among them, Figure 1 This is a comparison chart of the wound healing rates of rats in Example 1, the model control group, and the positive control group.

[0134] Wound secretion score

[0135] The guidelines for clinical research of new Chinese medicines (Trial) were used for formulation. Scoring was performed on the 3rd, 7th and 14th days after medication.

[0136] Wound secretion score: none - 1 point, a small amount - 2 points, a moderate amount - 3 points, and a large amount - 4 points;

[0137] The scores of wound secretions after surgery in each group of rats are shown in Table 2 below.

[0138] Table 2 Wound secretion scores of rats in each group at different time points [M(P25,P75), points]

[0139]

[0140] Note: In Table 2, a was compared with the model control group, P<0.05; b was compared with the comparative groups 1-6 and the positive control group, P<0.05.

[0141] From the results shown in Table 2 above, it can be seen that: 3 days after medication, there was no significant difference in the wound secretion scores of rats in each group (P>0.05). As the medication time prolonged, the wound secretion scores of rats in each group decreased. On the 7th and 14th days after medication, the wound secretion scores of Example 1-3 groups were lower than those of the model control group, comparative example 1-6 groups and positive control group, and the difference was statistically significant (P<0.05). However, there was no significant difference in the wound secretion scores of the model control group, comparative example 1-6 groups and positive control group (P>0.05). The above results show that the tissue regeneration and analgesic ointment prepared in this application can significantly reduce the secretion of wound secretions. Among them, Figure 2 This is a scoring chart of wound secretions of rats in Example 1, model control group, and positive control group.

[0142] Hematoxylin-eosin staining

[0143] On the 3rd, 7th and 14th days after medication, the postoperative healing tissues of the rats in each group (starting from the normal skin around the wound and deep to the wound base) were taken and fixed in 4% formaldehyde solution, routinely dehydrated, and then embedded in paraffin and sliced ​​continuously with a thickness of 5 μm. After hematoxylin-eosin staining, the changes of new blood vessels and fibroblasts were observed under a microscope.

[0144] The sections were imaged using a camera microscope. The pathological changes of wound tissues in the blank control group, model control group, Example 1 group, and positive control group (×200) are shown in Figure 3 , Figure 3 In the middle, the red arrow indicates inflammatory cells, the yellow arrow indicates focal hemorrhage, the green arrow indicates new capillaries, the blue arrow indicates fibroblasts, the black arrow indicates epidermis, and the orange arrow indicates multinucleated giant cells. The scale bar indicates 100 μm.

[0145] Depend on Figure 3The results show that: on the 3rd day, the skin tissue structure of the blank control group was clear, the thickness of the epidermis was uniform, the cells were arranged neatly, no obvious necrosis or shedding was observed, the number of collagen fibers in the dermis was abundant, the structures of the appendages such as hair follicles and cortical glands were clear, the fat cells and muscle fibers in the subcutaneous tissue were not obviously abnormal, and no obvious pathological changes were observed. The skin tissue of the model control group showed large-scale epidermal necrosis and shedding, accompanied by a large number of inflammatory cell infiltrations, a small amount of new blood vessels and fibroblast proliferation, and irregular cell arrangement. The skin tissue of the embodiment 1 group showed large-scale epidermal necrosis and shedding, and the dermis showed large-scale granulation tissue hyperplasia, a large number of fibroblast proliferation, and the cell arrangement was relatively regular. A large number of new blood vessels were observed, accompanied by a large number of inflammatory cell infiltrations. The skin tissue of the positive control group showed large-scale epidermal necrosis and shedding locally, and the dermis showed large-scale granulation tissue hyperplasia, a large number of fibroblast proliferation, and irregular local cell arrangement, more new blood vessels, and a large number of inflammatory cell infiltrations.

[0146] On the 7th day, the skin tissue structure of the blank control group was clear, the thickness of the epidermis was uniform, and the cells were arranged neatly, without obvious necrosis, falling off, the collagen fiber quantity was abundant in the dermis, the appendage structures such as hair follicles and cortical glands were clear, and the fat cells and muscle fibers in the subcutaneous tissue were without obvious abnormality, and no obvious pathological changes were seen. The skin tissue of the model control group showed epidermal necrosis and shedding on a large scale, and the granulation tissue hyperplasia in the dermis was visible on a large scale, and a large amount of fibroblasts and fibroblasts were hyperplastic, and the cells were arranged irregularly, and more inflammatory cells were infiltrated and angiogenesis was observed, and local hemorrhage and a small amount of small calcifications and multinuclear giant cells were observed. The skin tissue of the embodiment 1 group showed epidermal necrosis and shedding on a large scale, and the local visible epidermis was obviously thickened, and the granulation tissue hyperplasia in the dermis was visible on a large scale, and a large amount of fibroblasts were hyperplastic, and the fibroblasts were arranged more regularly, and more new blood vessels were observed, with a small amount of inflammatory cells infiltrating. In the positive control group, skin tissue showed extensive epidermal necrosis and shedding, extensive granulation tissue proliferation, more new blood vessels, and a large number of fibroblast proliferation in the dermis. Irregular arrangement of fibroblasts was observed in some parts, accompanied by moderate inflammatory cell infiltration.

[0147] On the 14th day, the skin tissue structure of the blank control group was clear, the thickness of the epidermis was uniform, the cells were arranged neatly, no obvious necrosis was seen, and the dermis was rich in collagen fibers, and the structures of the appendages such as hair follicles and cortical glands were clear. There was no obvious abnormality in the fat cells and muscle fibers in the subcutaneous tissue, and no obvious pathological changes were seen. The skin tissue of the model control group was locally necrotic and fell off, the epidermis was thickened, and the localized hemorrhage of the dermis was visible, and the granulation tissue in a large range was seen to be hyperplasia, a large amount of fibroblasts were hyperplasia, and the fibroblasts were arranged more regularly, and the new blood vessels were reduced, with a small amount of inflammatory cell infiltration. The visible epidermis of the skin tissue of the embodiment 1 group was obviously thickened, and the granulation tissue in a large range was seen to be hyperplasia, a large amount of fibroblasts were hyperplasia, and the cells were arranged regularly, dense, and a small amount of new blood vessels were seen, with a small amount of inflammatory cell infiltration. In the positive control group, the epidermis was thickened, granulation tissue was observed to proliferate in a large area in the dermis, a large number of fibroblasts proliferated, the arrangement of the fibroblasts was more regular, the number of new blood vessels was less than before, small calcification foci were occasionally seen, a small number of multinucleated giant cells were observed locally, accompanied by a small amount of inflammatory cell infiltration.

[0148] Masson staining

[0149] Rat wound tissue sections were selected at different time points and the collagen formation was observed under a microscope after Masson staining.

[0150] The slices were imaged using a camera microscope. After imaging, analysis software was used to measure the collagen pixel area and tissue pixel area in each image using pixel as the standard unit.

[0151] Calculation formula: collagen area = collagen pixel area / tissue pixel area × 100%.

[0152] The statistical analysis results are shown in Table 3 below. Figure 4 , Figure 5 .

[0153] Table 3 Comparison of collagen area ratio in rats of each group at different time points ( ±s,%)

[0154]

[0155] Note: In Table 3, a is compared with the model control group, P<0.05; b is compared with the comparative example 1-6 groups and the positive control group, P<0.05; c is compared with the blank control group, P<0.05.

[0156] From the results shown in Table 3 above, it can be seen that during the medication process, the collagen area ratio of each group of rats showed an upward trend. At 3, 7, and 14 days after medication, the collagen area ratio of Example 1-3 groups and the positive control group was higher than that of the model control group and the blank control group, and the collagen area ratio of Example 1-3 group was the highest (P<0.05), indicating that the muscle-generating and analgesic ointment prepared in this application and the first-generation product muscle-generating and analgesic ointment mentioned in the background technology can promote the formation of collagen fibers, and the muscle-generating and analgesic ointment prepared in this application has a more significant therapeutic effect. Pathological histology also showed that during the medication process, the number of collagen fibers in each group continued to increase, and the structure changed from chaotic to regular, while the amount of collagen fiber deposition in the wound tissue of Example 1-3 group was the largest, the fiber cords were thicker, the staining was darker, and the structure was denser. Among them, Figure 4 This is a graph showing the percentage of collagen area in the blank control group, Example 1 group, model control group, and positive control group; Figure 5 Figure 2 is a diagram of pathological changes in wound tissues of rats in the blank control group, model control group, Example 1 group, and positive control group (×200).

[0157] Immunohistochemistry

[0158] Rat wound tissue sections at different time points were selected, and the expression of PCNA protein in wound tissue was detected by immunohistochemistry to observe its changes during the treatment process.

[0159] The slices were imaged using a camera microscope. After imaging, analysis software was used to measure the number of positive cells in three fields of view of each slice, as well as the corresponding total number of cells, and the positive rate was calculated.

[0160] Calculation formula: Positive rate = number of positive cells / total number of cells × 100%.

[0161] The PCNA protein expression in wound tissue of rats in each group is shown in Table 4. Figure 6 , Figure 7 .

[0162] Table 4 The positive rate of PCNA protein expression in wound tissue of rats in each group ( ±s,%)

[0163]

[0164] Note: In Table 4, a is compared with the model control group, P<0.05; b is compared with the comparative example 1-6 groups and the positive control group, P<0.05; c is compared with the blank control group, P<0.05.

[0165] As shown in Table 4 above, after the third day of medication, the positive rate of PCNA protein expression in Example 1-3 group was the highest, which was significantly different from the blank control group, model control group, comparative example 1-6 group, and positive control group (P<0.05). There was a significant difference in the positive rate of protein expression between the comparative example 1-6 group, the positive control group, and the model control group (P<0.05), but there was no significant difference with the blank control group (P>0.05). There was no significant difference in the positive rate of protein expression between the model control group and the blank control group (P>0.05); after 7 days of medication, the positive rate of protein expression in Example 1-3 group continued to increase, which was significantly different from the positive control group (P<0.05). There was no significant difference in the positive rate of protein expression in the blank control group, model control group, comparative example 1-6 group, and positive control group (P>0.05); after 14 days of medication, the positive rate of protein expression in Example 1-3 group continued to increase, which was higher than that in the blank control group, positive control group, and model control group (P<0.05). There was no significant difference in the positive rate of protein expression among the blank control group, model control group, comparative example 1-6 groups, and positive control group (P>0.05). In summary, the myogenic analgesic ointment prepared in this application can promote PCNA protein expression during wound repair, and the effect is significantly better than that of the positive control group. Figure 6 This is a comparison chart of the positive rates of PCNA protein expression in rats in Example 1, the positive control group, the blank control group, and the model control group; Figure 7 The graph shows the PCNA expression in the wound tissue of rats in the blank control group, model control group, Example 1 group, and positive control group (×200).

[0166] Correlation factor detection

[0167] On the 3rd, 7th and 14th days after medication, blood was collected from the abdominal aorta of the rats in each group and the rats were killed. The levels of VEGF, bFGF and Ang-1 in serum were detected by ELISA.

[0168] The results of VEGF detection in rats of each group are shown in Table 5. Figure 8 .

[0169] Table 5 VEGF concentration in serum of rats in each group ( ±s, pg / ml)

[0170]

[0171] Note: In Table 5, a is compared with the model control group, P<0.05; b is compared with the comparative example 1-6 groups and the positive control group, P<0.05; c is compared with the blank control group, P<0.05.

[0172] From the data shown in Table 5 above, it can be seen that after 3 days of medication, the VEGF concentration in Example 1-3 groups was higher than that in Comparative Example 1-6 groups, the positive control group, the model control group and the blank control group (P<0.05). There was no significant difference in VEGF concentration among the Comparative Example 1-6 groups, the positive control group and the model control group (P>0.05), but they were all higher than the blank group (P<0.05). After 7 and 14 days of medication, the VEGF concentration in Example 1-3 groups was higher than that in the model control group and the blank control group (P<0.05), and there was no significant difference in VEGF concentration among the Comparative Example 1-6 groups, the positive control group and the model control group (P<0.05), but they were all higher than the blank control group (P<0.05). The results show that the myogenic analgesic ointment prepared in the present application can increase the concentration of VEGF in rat serum, and its therapeutic effect is significantly better than that of the model control group. Among them, Figure 8 This is a comparison chart of VEGF concentration values ​​(pg / ml) in the rat serum of the blank control group, Example 1 group, positive control group, and model control group.

[0173] The results of bFGF detection in rats of each group are shown in Table 6 below. Fig. 9 .

[0174] Table 6 bFGF concentration in serum of rats in each group ( ±s, pg / ml)

[0175]

[0176] Note: In Table 6, a is compared with the model control group, P<0.05; b is compared with the comparative example 1-6 groups and the positive control group, P<0.05; c is compared with the blank control group, P<0.05.

[0177] From the data shown in Table 6 above, it can be seen that: after 3 days and 14 days of medication, the bFGF concentration of Example 1-3 groups was higher than that of Comparative Example 1-6 groups, the positive control group, the model control group and the blank control group (P<0.05), while there was no significant difference in the bFGF concentration among the Comparative Example 1-6 groups, the positive control group and the model control group (P>0.05), but they were all higher than the blank control group (P<0.05). After 7 days of medication, the bFGF concentration of Example 1-3 groups, the model control group and the positive control group was higher than that of the blank control group (P<0.05), but there was no significant difference among the three groups (P>0.05). In summary, the muscle-generating and analgesic ointment prepared in the present application can increase the bFGF concentration in rat serum, and its therapeutic effect is significantly better than that of the positive control group. Among them, Fig. 9 The figure is a comparison chart of the bFGF concentration values ​​(pg / ml) in the peripheral blood of rats in Example 1, blank control group, model control group and positive control group.

[0178] The results of Ang-1 detection in rats of each group are shown in Table 7. Fig.10 .

[0179] Table 7 Ang-1 concentration in peripheral blood of rats in each group ( ±s, pg / ml)

[0180]

[0181] Note: In Table 7, a is compared with the model control group, P<0.05; b is compared with the comparative example 1-6 groups and the positive control group, P<0.05; c is compared with the blank control group, P<0.05.

[0182] From the data shown in Table 7 above, it can be seen that after the third day of medication, the concentration of Ang-1 in Example 1-3 groups was higher than that in Comparative Example 1-6 groups, the positive control group, the model control group and the blank control group (P<0.05), while there was no significant difference in the Ang-1 concentrations among the Comparative Example 1-6 groups, the positive control group and the model control group (P>0.05), but all were higher than the blank control group (P<0.05). After 7 days of medication, the concentration of Ang-1 in Example 1-3 groups was higher than that in the model control group and the blank control group (P<0.05). The concentrations of Ang-1 in the Comparative Example 1-6 groups, the positive control group and the model control group were all higher than that in the blank control group (P<0.05), and the Comparative Example 1-6 group was higher than the positive control group and higher than the model control group (P<0.05). After 14 days of medication, the concentration of Ang-1 in Example 1-3 groups was higher than that in the positive control group, the model control group and the blank control group (P<0.05). The Ang-1 concentrations of the comparative example 1-6 groups, the positive control group and the model control group were all higher than those of the blank control group (P<0.05), and the comparative example 1-6 groups were higher than the positive control group and higher than the model control group (P<0.05). In summary, the muscle-generating and analgesic ointment prepared in this application can increase the Ang-1 concentration in rat serum, and its therapeutic effect is significantly better than that of the positive control group. Among them, Fig.10 : This is a comparison chart of Ang-1 concentration values ​​in peripheral blood of rats in the blank control group, Example 1 group, model control group, and positive control group (pg / ml).

[0183] General condition of rats and postoperative wound morphology

[0184] The rats in the blank control group were in good overall condition, with moist fur, normal food and water intake, and normal defecation. The rats in the other groups were listless after modeling and debridement, with reduced food intake and activity, increased water intake, and congestion, swelling, and dark red wound surface.

[0185] On the third day after medication, the mental state of rats in each group improved, and their food intake and activity increased. The wound size of Example 1-3, Comparative Example 1-6, Model Control Group, and Positive Control Group did not change significantly compared with the previous wound. The wound was red and swollen with exudate, blood clots were locally present, and the surface was covered with light yellow necrotic tissue. No granulation tissue was observed in any group.

[0186] On the 7th day after medication, the mental state of each group of rats improved, and the amount of food intake and activity increased. The surface scabs of the embodiment 1-3 group, the comparative example 1-6 group, the model control group, and the positive control group were reduced to varying degrees compared with the previous wound surface, after removing the scab. The wound margin of the embodiment 1-3 group contracted centripetally, the wound area was significantly reduced, the edema was significantly alleviated, the secretions were reduced, the wound surface was moist and shiny, the granulation tissue hyperplasia was obvious, the color was bright red, dense, neat, and not higher than the wound margin. The wound margin of the model control group contracted, the wound area was reduced, the edema was alleviated compared with the previous, the secretions were many, the necrotic tissue of the wound surface did not completely fall off, the granulation tissue hyperplasia edema, higher than the wound margin. The wound margins of the comparative example 1-6 group and the positive control group contracted, the wound area was reduced, the edema was alleviated, the secretions were alleviated compared with the previous, a little necrotic tissue did not completely fall off, the granulation tissue hyperplasia edema, higher than the wound margin, and the visible epithelial tissue crawling of part of the wound margin.

[0187] On the 14th day after medication, the mental state, eating, drinking, and activity of rats in each group were basically normal. The wounds of Example 1-3, Comparative Example 1-6, Model Control Group, and Positive Control Group showed different degrees of healing tendency. The wounds of Example 1-3 Group have healed, the epithelial tissue is firm, and there is no bleeding when pressed. The wound area of ​​the rats in the model control group was significantly reduced, no obvious edema was observed, but there was a small amount of secretion, the inflammation was significantly improved, the granulation tissue grew well, and the wound edge had a tendency to crawl. Most of the wounds in Comparative Example 1-6 Groups were healed, and the unhealed wounds had no obvious edema and secretions. The granulation tissue was neatly arranged, ruddy in color, and obvious crawling, with a tendency to close. The wound area of ​​the rats in the positive control group was significantly reduced, the color was light red, there was no obvious edema and secretions, the granulation tissue of the wound grew well, the color was ruddy, and there was white epithelial growth on the wound edge, which tended to close. Among them, Fig.11 The figures are the wound healing conditions of rats in the model control group, positive control group and Example 1 group at different time points.

[0188] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed, but such modifications are protected by the patent law as long as they are within the scope of the claims of the present application.

Claims

1. A wound healing ointment for promoting tissue regeneration and relieving pain, characterized in that: The invention comprises a raw material medicine and a matrix. The raw material medicine is composed of the following raw materials in parts by weight: 30-50 parts of elephant skin, 24-28 parts of dragon's blood, 30-50 parts of corydalis, 15-25 parts of angelica dahurica, 28-40 parts of lithospermum officinale, 12-18 parts of sanguisorba officinalis, 10-15 parts of rubescens and 10-15 parts of seaweed.

2. The wound healing ointment according to claim 1, characterized in that: The raw material medicine is composed of the following raw materials in parts by mass: 40 parts of elephant peel, 25 parts of dragon's blood, 40 parts of corydalis, 20 parts of angelica dahurica, 30 parts of lithospermum officinale, 15 parts of sanguisorba officinalis, 12 parts of rubescens, and 12 parts of seaweed.

3. The wound healing ointment according to claim 1, characterized in that: The matrix comprises 700-900 parts of sesame oil and 180-250 parts of beeswax.

4. The wound healing ointment according to claim 3, characterized in that: The matrix comprises 800 parts of sesame oil and 200 parts of beeswax.

5. A method for preparing the myogenic and analgesic ointment for wound healing according to any one of claims 1 to 4, characterized in that: The following steps are involved: S1, respectively grinding elephant skin and dragon's blood to obtain elephant skin powder and dragon's blood powder, and grinding Corydalis yanhusuo, angelica dahurica, lithospermum officinale, sanguisorba officinalis, rubescens herb and seaweed to obtain mixed powder; S2, taking 50-80% of the weight of the mixed powder, extracting it with anhydrous ethanol and deionized water in turn, concentrating, drying and pulverizing it to obtain a mixed extract; S3. Simmer sesame oil over low heat until the oil boils, then add beeswax. Turn off the heat after the beeswax melts, add elephant skin powder and the remaining mixed powder while stirring, continue stirring until the system temperature is below 40°C, then add dragon's blood powder and the mixed extract to mix evenly, cool to a paste, and let stand at room temperature to obtain the desired tissue-growing and analgesic ointment.

6. The preparation method of the wound healing ointment according to claim 5, characterized in that: The elephant skin powder in step S1 is prepared by the following method: talcum powder is heated to 100-120° C. at a mass ratio of 1-2:1, and then poured into elephant skin cut into thin strips. When the elephant skin is scalded to bulge and turn brown, the talcum powder is sieved out, and the treated elephant skin is cooled and then ground into 100-150 mesh to obtain the elephant skin powder.

7. The method for preparing the wound healing ointment according to claim 5, characterized in that: The dragon's blood powder in step S1 is prepared by the following method: soaking the dragon's blood in deionized water for 1-2 hours until it is softened, blanching it in boiling water for 3-7 minutes for sterilization, drying it, and grinding it into 100-150 meshes to obtain the dragon's blood powder.

8. The method for preparing the wound healing ointment according to claim 5, characterized in that: In the step S1, the mixed drug powder is passed through a 100-150 mesh sieve.

9. The method for preparing the wound healing myogenic analgesic ointment according to claim 5, characterized in that: The specific operation steps of step S2 are as follows: Take 50-80% of the weight of the mixed powder and add anhydrous ethanol to reflux extract 1-3 times, combine the ethanol extract, add deionized water to the extracted drug residue and reflux extract 1-3 times, combine the water extract, concentrate the ethanol extract and the water extract under reduced pressure to recover the solvent, concentrate to a thick paste with a relative density of 1.30-1.36 at 80°C, dry at 60-80°C, and then grind into 100-150 mesh to obtain a mixed extract.

10. Use of the wound healing myogenic analgesic ointment according to any one of claims 1 to 4 in the preparation of a drug for promoting wound healing after perianal abscess surgery.